Fungicide Active Ingredients Market Size & Share 2026-2035

Fungicide Active Ingredients Market Size

The fungicide active ingredients market is valued at USD 20.9 billion in 2025 and is projected to reach USD 28 billion by 2035, expanding at an approximately 2.9% CAGR. Growth is underpinned by the need to protect crop output from disease while maintaining quality standards across agricultural and downstream food systems.

FAO estimates that plant pests and diseases cause losses of up to 40% of global crop production and cost the global economy more than USD 220 billion annually ^{[1]Food and Agriculture Organization of the United Nations, About FAO's work on Plant Production and Protection, fao.org}. Asian soybean rust alone can cause yield losses of up to 90% where it is not controlled.

The market sits upstream of formulated fungicide sales. Technical active ingredients are synthesized, traded, and incorporated into single-active products, premixes, and crop-specific formulations. This positioning makes value sensitive to both disease intensity and the mix of chemistries used per hectare. Resistance management increasingly favors programs that combine modes of action, while regulatory review can constrain the addressable use of legacy molecules. In Europe, chlorothalonil has been prohibited in plant protection products since May 2020 following non-renewal of its approval. Conversely, the European Commission renewed captan and folpet through October 2039, preserving two multisite options used in resistance-management programs.

Trade patterns illustrate the split between high-volume and differentiated supply. In 2024, the European Union exported USD 1.88 billion of retail-packaged fungicides, while China exported USD 1.11 billion and India USD 931 million; China and India shipped substantially larger volumes relative to export value than European suppliers ^{[2]World Integrated Trade Solution, World Bank, Fungicides, put up for retail sale: Exports by country, 2024 (HS 380820), wits.worldbank.org}. The difference is consistent with a market in which mature active ingredients compete through scale and cost, while proprietary chemistry, formulation technology, registrations, and crop-specific positioning sustain premium value.

This transition does not eliminate the importance of contact fungicides. The loss of solo QoI efficacy against septoria in Western European cereals and the monitoring of SDHI resistance make mode-of-action rotation and multisite partners commercially necessary in many programs. Suppliers with both a defensible innovation pipeline and the ability to formulate established chemistries into stewardship-aligned programs are better positioned than participants reliant on either commodity technical supply or a single proprietary molecule.

The market covers biologically active chemical compounds that provide antifungal properties in plant protection products and related agricultural, food industry, medicinal, and chemical laboratory applications. Estimates are expressed in USD billion, using 2025 as the base year and 2026–2035 as the forecast period.

Key Drivers

Crop-loss exposure sustains treatment demand. Fungal and oomycete disease management remains a direct economic requirement in intensive crop systems rather than a discretionary farm input. The severity of soybean rust, cereal diseases, potato blights, and other pathogen threats raises the cost of inadequate protection through lost yield, reduced marketability, and mycotoxin-related quality failures. As food production requirements rise, maintaining output from existing agricultural land increases the value of effective disease control.

Resistance management raises the importance of active-ingredient diversity. AHDB and FRAG guidance identifies widespread QoI resistance in *Zymoseptoria tritici* and advises use of fungicides within resistance-management programs rather than as repeated stand-alone treatments. European monitoring has also identified SDHI and DMI resistance alleles across major wheat-growing areas while FRAC's 2025 SDHI recommendations emphasize the continuing need for stewardship under high disease pressure. These conditions support premixes, rotations, and novel modes of action because growers must preserve efficacy across seasons rather than optimize solely for the lowest initial product cost.

New chemistry creates premium pricing opportunities. ADAMA's Gilboa, flumetylsulforim, is classified by FRAC in Group 32 and introduces a nucleic-acid-metabolism mode of action for cereal disease control ^{[3]ADAMA Ltd., ADAMA's Novel Active Ingredient Gilboa Introduces a New Mode of Action for Cereal Crops (FRAC Group 32), adama.com}. BASF submitted Adapzo Active, flufenoxadiazam, for registration in Brazil and Paraguay in June 2025 as an HDAC-inhibitor fungicide for Asian soybean rust ^{[8]BASF SE, BASF starts registration for new fungicide innovation Adapzo Active to control Asian Soybean Rust, June 2, 2025, basf.com}. FMC's fluindapyr has secured registrations across multiple markets, including Brazil and Argentina, broadening the commercial reach of a differentiated SDHI active ingredient.

Testing and compliance broaden non-field demand. Regulatory procedures for pesticide active substances and maximum residue limits require robust analytical evidence, expanding demand for high-purity standards and laboratory materials. This supports the Chemical Laboratory segment, which is projected to rise from USD 2.41 billion in 2025 to USD 3.42 billion by 2035.

Key Restraints

Registration decisions can remove or narrow market access. Chlorothalonil's European non-renewal demonstrates how environmental-fate concerns can eliminate a high-volume active ingredient from a major market. In the United States, EPA interim decisions issued in January 2025 for chlorothalonil, thiophanate-methyl, and carbendazim introduced mitigation measures including revised application conditions and protective requirements rather than cancelling registrations ^{[4]U.S. Environmental Protection Agency, EPA Announces Interim Decisions on Chlorothalonil, Thiophanate-Methyl and Carbendazim, January 8, 2025, epa.gov}. Canada also imposed updated chlorothalonil mitigation measures, including restrictions affecting certain potato and boom-sprayer applications.

Resistance shortens the effective economic life of established chemistry. Resistance creates demand for alternative products, but it also reduces the value of affected active ingredients and may limit label recommendations or stewardship flexibility. The commercial consequence is particularly acute for site-specific fungicides that must be protected with mixtures, application limits, and crop-specific management practices. Suppliers must maintain monitoring, formulation, and registration investment even after an active ingredient has reached technical maturity.

Renewal uncertainty raises compliance costs. The European Commission extended approval periods for several fungicide active substances in April 2025, including bixafen, fludioxonil, flutolanil, fluxapyroxad, penthiopyrad, and propamocarb, because assessments were not complete within existing timelines. Such extensions preserve short-term market access but leave registrants managing uncertainty over future approval outcomes. CropLife Europe's renewal monitor also documents the breadth of active substances subject to renewal processes and related submission requirements.

Inventory cycles and technical-material pricing create short-term volatility. The fungicide active-ingredient market can experience weak revenue realization even when disease risk and treated acreage remain structurally supportive. Inventory corrections at distributors and formulators delay replenishment, while commodity active ingredients are especially exposed to price competition. This reduces visibility for capacity planning and can widen the performance gap between producers of undifferentiated technical material and suppliers selling registered, crop-positioned formulations.

The more material risk lies in a simultaneous loss of access and affordability. If a legacy multisite active ingredient is removed without cost-effective substitutes, growers may face higher treatment costs or reduced program flexibility. Conversely, retained multisite options such as captan and folpet can become strategically more valuable because they help preserve the performance of site-specific chemistry in resistance-management systems.

Fungicide Active Ingredients Market Segment Analysis

By Active Ingredient Type

Azoxystrobin leads the named active-ingredient segments, rising from USD 4.9 billion in 2025 to USD 6.77 billion by 2035 at approximately 3.18% CAGR. Its broad crop relevance and role in mixtures support demand, but resistance management changes how it is deployed. In European cereal programs, widespread QoI resistance means azoxystrobin's commercial role is increasingly tied to combination products and non-septoria disease targets rather than solo use. ADAMA's March 2025 U.S. launch of Maxentis SC, combining prothioconazole and azoxystrobin, reflects this mixture-led positioning ^{[5]ADAMA US, ADAMA US launches Maxentis SC Fungicide, March 10, 2025, adama.com}.

Boscalid grows from USD 4.35 billion to USD 5.87 billion at approximately 2.98% CAGR. Its SDHI mechanism supports use in specialty and field crops, but the segment must navigate the broader SDHI resistance-management burden. BASF introduced Endura PRO for U.S. potato production in November 2024, pairing boscalid with mefentrifluconazole to address early blight and white mold. The combination illustrates how established SDHIs can retain value when formulation broadens disease coverage and reduces reliance on a single mechanism.

Chlorothalonil advances from USD 3.87 billion to USD 4.97 billion at approximately 2.47% CAGR, constrained by its European prohibition and tighter North American conditions. Its value remains linked to its multisite contact role in jurisdictions where it remains registered. Cyazofamid increases from USD 3.25 billion to USD 4.54 billion at approximately 3.34% CAGR. As a cyanoimidazole, FRAC Group 21 QiI active ingredient, it has differentiated relevance in oomycete programs, particularly for high-value crops where targeted disease control can justify premium input costs.

Etridiazole rises from USD 1.99 billion to USD 2.46 billion at approximately 2.07% CAGR. Its narrower soilborne-disease profile limits expansion relative to broad-spectrum actives. Fenarimol grows from USD 1.78 billion to USD 2.18 billion at approximately 1.97% CAGR, reflecting pressure from newer DMI options and the need for portfolios with stronger resistance-management and registration positions. The Others segment grows from USD 0.78 billion to USD 1.18 billion at approximately 4.18% CAGR, supported by newly commercialized chemistries and emerging specialty active ingredients.

By Mode of Action

Systematic fungicides constitute the largest segment, increasing from USD 7.4 billion in 2025 to USD 10.13 billion in 2035 at approximately 3.08% CAGR. Their ability to support preventive and curative programs makes them central to disease management in crops where application timing and internal redistribution influence field performance. The growth of fluindapyr-based products and newer modes of action reinforces the premiumization of this category.

Contact fungicides rise from USD 6.81 billion to USD 9.29 billion at approximately 3.10% CAGR. Their continued importance is tied to resistance stewardship, not merely historical usage. FRAG and FRAC guidance supports incorporating complementary modes of action and protecting site-specific chemistry, which preserves a role for contact and multisite materials where registrations permit.

Translaminar fungicides grow from USD 4.92 billion to USD 6.37 billion at approximately 2.56% CAGR. Their localized movement within leaf tissue can improve protection where coverage conditions are challenging, although growth trails systematic and contact categories. The Others mode-of-action category represents the market's capacity to absorb new chemistries as registration and field adoption develop.

By End Use

Agriculture remains the largest end use, expanding from USD 8.2 billion in 2025 to USD 10.69 billion in 2035 at approximately 2.66% CAGR. It is the segment most exposed to seasonal disease pressure, registration changes, and farm-level affordability. Food Industry demand grows from USD 5.97 billion to USD 8.17 billion at approximately 3.13% CAGR, supported by post-harvest protection needs and residue-compliance requirements in traded food supply chains.

Medicinal applications increase from USD 2.94 billion to USD 3.70 billion at approximately 2.26% CAGR. Demand is selective because agricultural fungicide active ingredients are not interchangeable with clinical antifungal ingredients, but certain compounds remain relevant as analytical materials, intermediates, or research inputs. Chemical Laboratory is the fastest-growing end use, rising from USD 2.41 billion to USD 3.42 billion at approximately 3.50% CAGR. The segment benefits from active-substance and MRL application procedures that require analytical reference materials and robust residue-testing capability ^{[6]European Food Safety Authority, Pesticides: Active substance and MRL application procedures, efsa.europa.eu}.

The 4.18% growth forecast for Others signals that portfolio renewal is likely to be a larger source of incremental value than broad volume expansion in mature chemistries. Laboratory demand adds a second layer of resilience: regulatory testing expands the value of high-purity active ingredients even when agricultural application rules become more restrictive. Manufacturers able to meet both formulation and analytical-grade requirements can diversify revenue without depending solely on field-use volume.

Fungicide Active Ingredients Market Regional Analysis

North America

North America is valued at USD 6.81 billion in 2025 and is projected to reach USD 9.29 billion by 2035, growing at approximately 3.10% CAGR. The United States accounts for USD 5.44 billion of the 2025 regional value, while Canada represents the remaining approximately USD 1.37 billion. Corn, soybean, cereal, potato, and specialty-crop disease programs support demand for systematic and contact active ingredients. Regulatory conditions are a central market variable: EPA's January 2025 interim decisions retained registrations for several fungicide active ingredients while tightening risk-mitigation requirements and Canada introduced further chlorothalonil measures in 2024. Compliance capability therefore becomes part of commercial competitiveness.

Europe

Europe grows from USD 3.87 billion in 2025 to USD 5.37 billion in 2035 at approximately 3.27% CAGR, the highest regional rate. Germany, the UK, France, Spain, Italy, and the Rest of Europe combine intensive cereal production with high-value specialty crops. The region's growth is driven by portfolio replacement rather than unrestricted expansion of chemical use. Chlorothalonil's removal, extended approval reviews for other active substances, and continuing septoria resistance pressure favor products that can satisfy both stewardship and regulatory requirements.

France is also a significant export hub, shipping USD 1.46 billion and 115.9 million kg of retail-packaged fungicides in 2024. This supply role strengthens the importance of European registration decisions beyond domestic consumption because approved active ingredients and formulations can serve multiple export markets.

Asia Pacific

Asia Pacific is the largest regional market, increasing from USD 7.85 billion in 2025 to USD 10.69 billion by 2035 at approximately 3.07% CAGR. China and India combine major agricultural demand with substantial fungicide production and export activity. China exported 243.7 million kg of retail-packaged fungicides in 2024, while India exported 291.0 million kg, the highest country volume reported in the cited trade dataset.

The region is not solely a low-cost supply base. BASF launched Cevya, a mefentrifluconazole-based rice fungicide, in China in June 2024; BASF described it as the first isopropanol triazole fungicide registered on rice in China in more than two decades ^{[7]BASF SE, BASF launches new rice fungicide Cevya in China, June 12, 2024, basf.com}. The launch demonstrates that rice disease management and high-value crop systems can support differentiated active ingredients despite intense generic competition.

Latin America

Latin America rises from USD 1.33 billion in 2025 to USD 1.52 billion by 2035 at approximately 1.25% CAGR. Brazil remains the region's principal demand center because soybean, corn, and cotton production require sustained disease-management programs. Yet regional market value is highly sensitive to farm economics, channel inventory, exchange-rate movements, and generic price competition. These factors can restrain value growth even when disease pressure remains high.

Innovation activity is nonetheless significant. BASF submitted Adapzo Active for Brazilian registration in June 2025 for Asian soybean rust while FMC received registration in Brazil for fluindapyr fungicide technology. These developments indicate that suppliers view Brazil as a strategically important market for resistance-management chemistry, even where near-term pricing conditions limit aggregate market expansion.

Middle East & Africa

Middle East & Africa grows from USD 1.08 billion in 2025 to USD 1.10 billion by 2035 at approximately 0.11% CAGR. Limited irrigated acreage in parts of the Middle East, uneven distribution infrastructure, constrained farm finance, and variable regulatory capacity suppress the region's aggregate growth rate. Demand is more concentrated in protected horticulture, export-oriented fruit and vegetable production, South African wine and field crops, and higher-value greenhouse systems. These applications favor targeted disease control but do not yet offset the broader structural constraints on adoption.

Asia Pacific remains the largest market because it combines extensive crop production with technical-material and formulated-product supply. Latin America presents a different commercial proposition: its disease-management need is substantial, but value realization is more exposed to distributor inventories and price competition. Launch sequencing should therefore distinguish between markets that reward premium registration-backed solutions and markets where technical cost, local formulation, and channel discipline are decisive.

Fungicide Active Ingredients Market Share & Competitive Landscape

ADAMA combines established fungicide formulations with investment in differentiated active ingredients. Its March 2025 U.S. launch of Maxentis SC positioned a prothioconazole-azoxystrobin mixture for corn, soybean, and wheat disease control. ADAMA also introduced Avastel and Maganic cereal fungicides in 2024, extending its European cereal portfolio. The company's longer-term differentiation rests on Gilboa and its December 2025 co-development agreement with BASF.

BASF SE maintains broad fungicide exposure across SDHI, triazole, and novel-chemistry categories. Cevya's China launch and Endura PRO's U.S. potato introduction demonstrate its ability to localize active ingredients by crop and disease problem. Its Adapzo Active program addresses a more strategic requirement: a new mode of action aimed at Asian soybean rust, where resistance pressure elevates the value of differentiated chemistry.

Bayer AG remains positioned in systemicfungicide and seed-treatment chemistry. Bayer Crop Science New Zealand reported the registration of Emesto Prime for in-furrow control of potato black scurf in August 2025, extending the commercial application of penflufen in a disease-specific setting ^{[9]Bayer Crop Science New Zealand, Emesto Prime fungicide registered for in-furrow use to control black scurf in potatoes, August 20, 2025, cropscience.bayer.co.nz}. Its competitive relevance depends on combining established chemistry with stewardship practices necessary for SDHI and azole programs.

Corteva Agriscience is reshaping its fungicide portfolio around premium mixtures. The company completed the divestiture of its solo mancozeb business to UPL in April 2024. Corteva's proposed Forcivo fungicide combines flutriafol, azoxystrobin, and fluindapyr for U.S. foliar disease control, subject to EPA registration. Its collaboration with FMC broadens access to fluindapyr technology while reducing the need to originate the active ingredient internally.

FMC Corporation's fungicide strategy is centered on fluindapyr. The company expanded the technology through registrations and launches including Tremisia in Ukraine and Fidresa in Argentina during 2025. FMC also collaborated with Corteva to make fluindapyr technology available to additional U.S. corn and soybean growers. Its 2025 annual report identifies fluindapyr as a key commercial fungicide asset, while FMC India's 2024 launches of VELZO and COSUIT extend its fruit and vegetable disease-management presence.

NIPPON SODA CO LTD. develops value from established proprietary fungicide registrations through crop and use extensions. Registration notices in 2024 expanded Fantasista WG to additional crops and expanded Fronside SC uses, illustrating a strategy based on extracting further value from existing active-ingredient assets in Japanese agriculture.

Nissan Chemical Corporation remains part of the defined competitive scope through its agricultural-chemicals activities and its historical participation in European distribution vehicles. Sumitomo Chemical's 2025 acquisition activity involving Philagro and Kenogard consolidated channels in which Nissan Chemical had held minority interests. The development highlights how distribution control can influence market access for active ingredients even where product innovation occurs elsewhere in the value chain.

Nufarm competes through generic and specialty crop-protection portfolios and regional commercialization capability. Its relationship with Sumitomo Chemical evolved following Sumitomo's sale of its Nufarm shareholding, while the two companies retained commercial links across multiple markets. This structure supports Nufarm's role as a route-to-market participant for established and specialty fungicide products rather than solely a technical-material supplier.

Sumitomo Chemical Co. Ltd. strengthened its European crop-protection platform through the January 2025 full acquisition of Philagro Holding and an agreement to acquire Kenogard. The transaction increases control over European distribution and creates a broader route to commercialize proprietary fungicides and biorational offerings. Its earlier acquisition of Nufarm's South American crop-protection business also provides regional infrastructure in markets where soybean and cereal disease management are commercially important.

Syngenta AG remains a major competitor within the defined company scope, particularly where proprietary mixtures, global registration capability, and broad crop portfolios differentiate commercial offerings from commodity active-ingredient supply. Its competitive position is shaped by the same transition affecting the wider market: established active ingredients require formulation, crop positioning, and stewardship support to retain value as patents expire and resistance evolves.

UPL Limited strengthened its multisite fungicide portfolio through the April 2024 completion of its acquisition of Corteva's solo mancozeb business, including the Dithane brand, Rainshield technology, regulatory dossier, and trademarks in covered markets. The acquisition gives UPL a stronger position in contact-fungicide programs, where multisite chemistry can remain commercially important as a resistance-management partner.

Recent Industry Developments

In April 2024, UPL completed its acquisition of Corteva's solo mancozeb business, including the Dithane brand, Rainshield technology, and associated regulatory assets in the covered territories.

In June 2024, BASF launched Cevya in China for rice disease management, based on mefentrifluconazole.

In July 2024, FMC India launched VELZO and COSUIT fungicides for fruit and vegetable disease-management programs.

In September 2024, the European Commission renewed approval for folpet through October 2039.

In November 2024, the European Commission renewed approval for captan through October 2039. BASF also introduced Endura PRO for U.S. potato growers during November 2024.

In January 2025, Sumitomo Chemical completed the acquisition of Philagro Holding and announced an agreement to acquire Kenogard. EPA issued interim decisions for chlorothalonil, thiophanate-methyl, and carbendazim that month.

In March 2025, ADAMA US launched Maxentis SC fungicide for corn, soybean, and wheat disease management.

In June 2025, FMC and Corteva announced a collaboration to expand U.S. grower access to fluindapyr fungicide technology. FMC also expanded fluindapyr to the EMEA region through the Ukrainian registration of Tremisia. BASF submitted Adapzo Active registration dossiers in Brazil and Paraguay during the same month.

In December 2025, ADAMA and BASF announced a co-development and commercialization agreement for Gilboa fungicide technology.